Jubilant, Sun Pharma, and Lupin recall products from the US market citing different reasons : The United States is the world’s largest market for medicines. Recently, three major pharma firms have initiated a voluntary products recall from the US market. Lupin US–based unit of Lupin has initiated a Class II recall of over 17,814 bottles […]
Jubilant, Sun, and Lupin initiated products recall Read More »
USFDA approves Gland Pharma’s generic Foscarnet Sodium Injection, single – dose bag for infusion : Gland Pharma had sought out the USFDA’s[1] approval for one of its generic products. This product is called Foscarnet Sodium injection, 6000 mg/ 250 mL ( 24 mg/ mL ) Single-Dose Bag for Infusion. On 22 April 2021, the company
USFDA approves Gland Pharma’s Foscarnet Injection Read More »
China’s NMPA approves AstraZeneca’s drug Tagrisso as adjuvant therapy for patients with early – stage lung cancer : China’s health regulator has recently expanded the use of Tagrisso in patients with a type of lung cancer. This was announced on 14 April 2021. Tagrisso is a drug indicated for lung cancer treatment and is manufactured
NMPA approves Tagrisso as an adjuvant therapy in early–stage lung cancer. Read More »
South Korea strikes a deal with Pfizer to procure additional 40 million doses of its COVID – 19 vaccine : South Korea has recently been actively procuring COVID – 19 vaccines from many pharma majors. Over 192 million doses of the vaccines have been secured from various companies to date. This includes vaccines from Moderna,
VAV Lifesciences to supply Pfizer and Moderna the Crucial ingredient for mRNA – based COVID – 19 vaccines Mumbai – based VAV Lifesciences is the only domestic firm that produces phospholipids and lecithins. A phospholipid is a crucial ingredient of the mRNA[1] – based COVID – 19 vaccines. Recently, this company has signed an agreement
VAV Lifesciences: mRNA – based vaccine supply chain Read More »
Novel oral formulation of Remdesivir developed by Jubilant Pharma seeks DCGI’s approval Jubilant Pharma has recently announced the development of the oral formulation of Remdesivir. The formulation is Remdesivir with NDDS (Novel Drug Delivery system) Per the company, this move will help to ease the capacity constraints faced by the injectable formulation. It also added
Clinical bridging trials of Johnson & Johnson’s single – dose COVID – 19 vaccine to begin shortly in India : Johnson & Johnson ( J&J ) has recently communicated with the CDSCO[1] to ramp up vaccine availability in the country. The company has sent a letter to the Indian regulator on this matter. It stated
Panacea Biotec partners with RDIF to manufacture 100 million doses of Sputnik V in India annually : India has been emerging as the manufacturing hub of the Russian COVID – 19 vaccines, Sputnik V. Stelis Pharma (Strides arm), Hetero, Gland Pharma, and Virchow group are the key manufacturers of the vaccine. These pharma companies have
Sputnik V: RDIF to manufacture 100 million doses Read More »
ISSAR pharma licenses its NCEs based on peptide technology in hopes of potential collaborations : ISSAR has been on the lookout for partnering with other companies to get assistance in designing novel peptide–based drugs. It believes that collaborations would allow it to make affordable and accessible drugs for various unmet healthcare needs. In line with
IDT Biologika agrees to produce over 10 million doses of AstraZeneca’s COVID – 19 vaccine : IDT Biologika has recently announced its plan to manufacture around 10 million doses of AstraZeneca’s COVID – 19 vaccine. The German vaccine – maker made this announcement on 16 April 2021 and added that IDT would produce the doses
IDT Biologika agrees to produce Astra’s COVID vaccine Read More »
